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Extent and determinants of error in doctors’ prognoses in
terminally ill patients: prospective cohort study
Nicholas A Christakis, Elizabeth B Lamont
Abstract
Objective To describe doctors’ prognostic accuracy in
terminally ill patients and to evaluate the
determinants of that accuracy.
Design Prospective cohort study.
Setting Five outpatient hospice programmes in
Chicago.
Participants 343 doctors provided survival estimates
for 468 terminally ill patients at the time of hospice
referral.
Main outcome measures Patients’ estimated and
actual survival.
Results Median survival was 24 days. Only 20%
(92/468) of predictions were accurate (within 33% of
actual survival); 63% (295/468) were overoptimistic
and 17% (81/468) were overpessimistic. Overall,
doctors overestimated survival by a factor of 5.3. Few
patient or doctor characteristics were associated with
prognostic accuracy. Male patients were 58% less
likely to have overpessimistic predictions.
Non-oncology medical specialists were 326% more
likely than general internists to make overpessimistic
predictions. Doctors in the upper quartile of practice
experience were the most accurate. As duration of
doctor-patient relationship increased and time since
last contact decreased, prognostic accuracy decreased.
Conclusion Doctors are inaccurate in their prognoses
for terminally ill patients and the error is
systematically optimistic. The inaccuracy is, in general,
not restricted to certain kinds of doctors or patients.
These phenomena may be adversely affecting the
quality of care given to patients near the end of life.
Introduction
Although doctors commonly have to prognosticate,
most feel uncomfortable doing so.
1 Neither medical
training
1 2 nor published literature
3 4 treat prognostica-
tion as important, and prognostic error is widespread.
2
Unfortunately, prognostic error may have untoward
effects on both patient care and social policy.
Parkes showed that doctors’ predictions of survival
in 168 cancer patients were often erroneous and opti-
mistic,
5 and these findings were confirmed by
subsequent studies.
6–10 However, previous work has
been limited by use of small samples of patients and
very small samples of prognosticators (typically fewer
than four); failure to examine whether certain types of
doctors are more likely to err in certain types of
patients; and neglect of the possibility of different
determinants of optimistic and pessimistic error.
Therefore, we conducted a large, prospective cohort
study of terminally ill patients to evaluate the extent
and determinants of prognostic error.
Participants and methods
Our cohort consisted of all patients admitted to five
outpatient hospice programmes in Chicago during
130 consecutive days in 1996. Participating hospices
notified us about patients on admission, and we imme-
diately contacted the referring doctors to administer a
four minute telephone survey. Of the 767 patients
(referred by 502 doctors), 65 did not meet the entry
criteria (they were children, were denied hospice
admission, or refused to give consent) and 51 died
before we were notified (and thus survival predictions
would be meaningless). Of the remaining 651 patients,
for 66 (10%) we contacted the doctor only after the
patient’s death (and so could not get meaningful prog-
noses), for 14 (2%) the doctor refused to participate,
and for 67 (10%) the doctor could not be contacted.We
thus completed surveys with 365 different doctors car-
ing for 504 patients (504/651=77%). Comparison of
these 504 patients with the 147 excluded patients
showed no important differences in patient or doctor
characteristics. On 30 June 1999 we had dates of death
for 486 of the 504 patients (96%). Because data were
occasionally missing, not all totals in the analyses are
equivalent.
We obtained the patients’ age, sex, race, religion,
marital status, diagnosis, and comorbidities from the
hospice. From the survey, we obtained an estimate of
how long the patient had to live;information about the
patient, including Eastern Cooperative Oncology
Group performance status
11 and duration of illness;
information about the doctor, including experience
with similar patients and self rated dispositional
optimism; and information about the doctor-patient
relationship, including the duration, recentness, and
frequency of contact. We obtained other data on the
doctors, such as specialty, years in practice, and board
certification from public records. Dates of patients’
deaths were obtained from public death registries or
the hospices.
We divided the observed by the predicted survival,
and deemed prognoses “accurate” if this quotient was
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469 BMJ VOLUME 320 19 FEBRUARY 2000 www.bmj.combetween 0.67 and 1.33. Values less than 0.67 were
“optimistic” prognostic errors and those greater than
1.33 were “pessimistic.” We conducted analyses using
different cut off points or more categories, as well as
analyses that treated this quotient as a continuous
measure, but these analyses did not contravene the
results presented.To evaluate associations between cat-
egorical and continuous variables and the trichoto-
mous prognostic accuracy variable,we used  
2 tests and
analysis of variance respectively. We used multinomial
logistic regression to assess the multivariate effect of
patient and doctor variables on prognostic accuracy.
Results
The patients had a mean age of 69 (SD 17) years and
225/504 (45%) were men. The diagnosis was cancer in
326 (65%), AIDS in 62 (12%), and other conditions in
116 (23%). The mean duration of disease was 83.5
(135.8) weeks, and the median performance status
was 3 (corresponding to >50% of the day spent
bedridden). The doctors had a median duration of
medical practice of 16 years;291/363 (80%) were men;
293/365 (80%) were board certified; and 255/345
(74%) rated themselves optimistic. A total of 114/358
(32%) specialised in general internal medicine, 71/358
(20%) in non-oncological internal medicine subspe-
cialties, 61/358 (17%) in oncology, 55/358 (15%) in
family or general practice, 27/358 (8%) in geriatrics,
and 30/358 (8%) were surgeons or practised other
specialties. In the past year, the doctors had had
experience caring for a median of five patients with the
same diagnosis and had referred a median of eight
patients to a hospice. They had known the patient an
average of 159 (308) weeks; had 11 (14) contacts in the
previous three months; and had examined the patient
14 (29) days before.
Doctors’ prognostic estimates
In only 18 of 504 patients did the doctor refuse to pre-
dict survival to us. Eighteen of the remaining 486 had
missing dates of death, leaving 468 cases referred by
343 doctors for analysis of prognostic accuracy. The
figure illustrates the extent of the error. The median
observed patient survival was 24 days. The mean ratio
of predicted to observed survival was 5.3. The correla-
tion between predicted and observed survival was 0.28
(P<0.01). When an accurate prediction was defined as
between 0.67 and 1.33 times the actual survival, 20%
(92/468) of predictions were accurate, 63% (295/468)
optimistic, and 17% (81/468) pessimistic. When an
accurate prediction was defined as between 0.50 and
2.0 times the actual survival, 34% (159/468) of predic-
tions were accurate, 55% (256/468) optimistic, and
11% (53/468) pessimistic. Death occurred within one
month of the predicted date for 42% (195/468) of
patients, at least one month before the predicted date
in 46% (214/468), and at least one month after the
predicted date in 13% (59/468) of patients.
The extent of prognostic error varied depending
on both observed and predicted survival (table). The
longer the observed survival (that is, the less ill the
patient),the lower the error,and,conversely,the longer
the predicted survival, the greater the error.
Factors associated with prognostic accuracy
Bivariate analyses of the trichotomous accuracy
variable and patient attributes showed no important
differences with respect to patients’ age, sex, race,
religion, or marital status. However, cancer patients
were the most likely to have overoptimistic predictions
(220/301 (67%) v 37/58 (64%) of AIDS patients and
56/109 (51%) of other patients) and the least likely to
have overpessimistic predictions (39/301 (13%) v
13/58 (22%) and 29/109 (27%)); AIDS patients were
the least likely to have correct predictions (8/58 (14%)
v 60/301 (20%) of cancer patients and 24/109 (22%) of
others; P <0.01).
Bivariate analyses of the doctor attributes showed
no important differences with respect to sex, years in
medical practice, board certification, self rated opti-
mism, number of hospice referrals in past year, or
number of medically similar patients in the past year.
However, doctors in non-oncological medical subspe-
cialties were the least likely to give correct estimates
(8/79 (10%) v 11/30 (37%) doctors in surgery or other,
18/76 (27%) in family or general practice, 24/105
(23%) in oncology, and 30/180 (17%) in geriatric or
general internal medicine), and oncologists were the
least likely to be overpessimistic in their estimates
(10/105 (9%) v 21/79 (27%) in other internal medicine
subspecialties, 13/67 (19%) in family or general
practice, 31/180 (17%) in geriatric or general internal
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Predicted versus observed survival in 468 terminally ill hospice
patients. Diagonal line represents perfect prediction. Patients above
diagonal are those in whom survival was overestimated; patients
below line are those in whom survival was underestimated
Doctors’ overestimates of patient survival by observed and
predicted survival
% overestimate in survival
(mean) No of patients
Observed survival (days):
1-30 795 251
31-90 288 130
91-180 136 49
>180 71 38
Overall 526 468
Predicted survival (days):
1-30 192 150
31-90 382 144
91-180 501 119
>180 1872 55
Overall 526 468
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P < 0.01).
Among the doctor-patient relationship variables
(such as length of professional relationship, number of
recent contacts, time since last examination), the inter-
val since last examination was important:overpessimis-
tic predictions were associated with the most recent
examinations (7.5 days), overoptimistic predictions
with the next most recent examinations (13.8 days),
and the correct predictions with the longest interval
since physical examination (19.5 days); P<0.05.
The trichotomous prognosis variable was regressed
on patients’ age, sex, race, diagnosis, duration of
disease, and performance status and on doctors’
experience,sex,optimism,board certification,specialty,
related practical experience, duration of relationship,
number of contacts,and interval since last examination
(full results available on the BMJ’s website). The model
showed that doctors’ prognostic accuracy was inde-
pendent of most patient and doctor attributes.
However, after other attributes were adjusted for, male
patients were 58% less likely to have overpessimistic
than correct predictions (odds ratio 0.42; 95%
confidence interval 0.18 to 0.99). Doctors in the upper
quartile of practice experience were 63% less likely to
make optimistic rather than correct predictions (0.37;
0.19 to 0.74) and 78% less likely to make pessimistic
rather than correct predictions (0.22; 0.08 to 0.61).
Doctors with medical subspecialty training (excluding
oncologists) were 3.26 times more likely than geriatri-
cians and general internists to make pessimistic rather
than correct predictions (3.26; 1.01 to 10.7). As the
duration of the doctor-patient relationship increased,
so too did the doctor’s odds of making an erroneous
prediction—for example, each one year longer that the
doctor had known the patient resulted in a 12%
increase in the odds of an overpessimistic prediction
(1.12;1.02 to 1.22).Also,as the interval since last physi-
cal examination increased,the odds of a doctor making
a pessimistic rather than a correct prediction
decreased;each day longer resulted in a 3% decrease in
the odds (0.97; 0.94 to 0.99).
Discussion
Our study of 365 doctors and 504 hospice outpatients
found that only 20% of prognoses were accurate. Most
predictions (63%) were overestimates, and doctors
overall overestimated survival by a factor of about five.
These prognoses were doctors’best guesses about their
patients’ survival prospects, objectively communicated
to the investigators and not to patients themselves.
Close multivariate examination showed that most doc-
tor and patient attributes were not associated with
prognostic error. However, the tendency of doctors to
make prognostic errors was lower among experienced
doctors. Moreover, the better the doctor knew the
patient—as measured, for example, by the length and
recentness of their contact—the more likely the doctor
was to err.
These findings have several implications. Firstly,
undue optimism about survival prospects may contrib-
ute to late referral for hospice care, with negative
implications for patients.
12 13 Indeed, although doctors
state that patients should ideally receive hospice care
for three months before death,
14 patients typically
receive only one month of such care.
15 The fact that
doctors have unduly optimistic ideas about how long
patients have to live may partly explain this
discrepancy. Doctors who do not realise how little time
is left may miss the chance to devote more of it to
improving the quality of patients’ remaining life.
Secondly, to the extent that doctors’ implicit or explicit
communication of prognostic information affects
patients’ own conceptions of their future, doctors may
contribute to patients making choices that are counter-
productive. Indeed, one study found that terminally ill
cancer patients who hold unduly optimistic assess-
ments of their survival prospects often request futile,
aggressive care rather than perhaps more beneficial
palliative care.
16 Thirdly, our work hints at corrective
techniques that might be used to counteract prognos-
tic error. Disinterested doctors, with less contact with
the patient, may give more accurate prognoses,
perhaps because they have less personal investment in
the outcome.
17 Clinicians may therefore wish to seek
“second opinions” regarding prognoses, and our work
suggests that experienced doctors may be a particu-
larly good source of opinion.Finally,our work suggests
that prognostic error in terminally ill patients is rather
uniformly distributed. This has implications for
doctors’ training and self assessment since it suggests
that there is not one type of doctor who is prone to
error, nor is there one type of patient in whom doctors
are likely to err.
Obtaining prognostic information is often the
highest priority for seriously ill patients, eclipsing their
interest in treatment options or diagnostic details.
18 19
And reliable prognostic information is a key determi-
nant of both doctors’ and patients’ decision mak-
ing.
16 20 21 Although some error is unavoidable in
prognostication, the type of systematic bias towards
optimism that we have found in doctors’ objective
prognostic assessments may be adversely affecting
patient care.
We thank Elena Linden and Tammy Polonsky for help in
administering the survey.
What is already known on this topic
Doctors’ prognostic estimates are a central
element of both patient and physician decision
making, especially at the end of life
Doctors’ prognostic estimates in their terminally ill
patients are often wrong and usually optimistic
What this study adds
A prospective cohort study of 504 terminally ill
patients and their 365 doctors found that only
20% of the doctors’ predictions were accurate:
63% were overoptimistic and 17% overpessimistic
Multivariate modelling showed that most types of
doctors are prone to error, in most types of
patients
The greater the experience of the doctor the
greater the prognostic accuracy, but a stronger
doctor-patient relationship is associated with lower
prognostic accuracy
Papers
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Commentary: Why do doctors overestimate?
Julia L Smith
American doctors refer patients to hospice too late.
Christakis and Lamont’s research shows that doctors
are poor prognosticians and tend to overestimate how
long a person who is terminally ill will live.
Most of the patients in their study had cancer
(65%). This is a similar proportion to that found in
hospice patients in a survey carried out in 1995 (60%),
despite the fact that cancer is not the leading cause of
death in the United States. Seven per cent of the
patients referred to these hospices died within hours of
admission. This eleventh hour referral pattern is at
least partly due to doctors not recognising the
nearness of death.
A patient is eligible for hospice care if they have an
estimated life expectancy of six months or less. As the
authors point out, the actual length of stay is usually
less than six weeks. Thus most patients come to
hospice during a period of rapid physical change and
often in crisis. And they don’t live long beyond the cri-
sis.
At times of crisis, the immediate management of
symptoms and relieving the family overshadows the
need to address the emotional and spiritual issues of
remembering, forgiving, and bringing to closure the
issues of a person’s life. Provision of a physically
comfortable death is a worthy goal. It reduces regrets
among survivors. Yet more time provides the
opportunity for the dying person to participate directly
in the process of validating the past and planning for
the future and gives the family the chance to relish or
repair bonds with the dying person.The National Hos-
pice Organisation has tried to educate doctors on how
to predict appropriate entry points to hospice for vari-
ous conditions.
1 These guidelines should be incorpo-
rated into the general education of doctors.
The authors’ suggestion that prognostication
should be done by a “disinterested” experienced
doctor hits near one common thread of late hospice
referrals.Doctors may be reluctant to acknowledge that
patients they know well are close to death. This can be
compounded by the patient’s and family’s preference
to keep hoping for the patient to live longer. Those of
us who know our patients longer often become
attached to them. We, too, hate to admit that death is
near. I remember a woman in her 60s I was treating for
metastatic breast cancer. She was admitted to the hos-
pital with gastric bleeding that was thought to be unre-
lated to her cancer. I remember talking to her and her
husband and being optimistic about the reversibility of
the problem.Because I was trying not to scare her I did
not discuss the issues of advanced directives and resus-
citation. That night she went into shock, required intu-
bation, and went to the intensive care unit. Her
husband was devastated and angry that she had had
such treatment.The next day he and I together decided
that no additional treatment would be given to prevent
her death. He sat with her for over 24 hours before she
died. My desire to be optimistic prolonged her dying
and added anguish to her husband. Doctors often rail
against the denial of patients and their families. Yet we
are not immune.
Decisions at the end of life are not just guided by
doctors. There is a complex interaction of doctor
recognising and acting on accurate prognostication,
what the doctor tells the patient and family, and what
the patient and family actually hear. Christakis and
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